|
|
Volumn 15, Issue 4, 1997, Pages 357-359
|
|
Phase II evaluation of topotecan in patients with advanced colorectal cancer. A Southwest Oncology Group trial (SWOG 9241)
a
|
|
Author keywords
Colorectal cancer; Topoisomerase 1 inhibitor; Topotecan
|
|
Indexed keywords
DNA TOPOISOMERASE INHIBITOR;
TOPOTECAN;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
BONE MARROW SUPPRESSION;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONTROLLED STUDY;
GRANULOCYTOPENIA;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SURVIVAL TIME;
THROMBOCYTOPENIA;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
COLORECTAL NEOPLASMS;
DISEASE PROGRESSION;
FEMALE;
HUMANS;
INJECTIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
SURVIVAL ANALYSIS;
TOPOTECAN;
|
|
EID: 0031424630
PISSN: 01676997
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1005941603420 Document Type: Article |
|
Times cited : (18)
|
|
References (6)
|
